| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3375273 | Journal of Infection | 2009 | 7 Pages |
Abstract
VAP linked to P. aeruginosa Type III phenotype portrays a divergent antibiotic treatment response in regards to the concentrations of metalloproteinases in the alveolar space. The imbalance between MMP-9 and TIMP-1 may determine the intensity of alveolocapillary damage and ultimate outcome of P. aeruginosa VAP.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Ali A. El-Solh, Daniel Amsterdam, Ahmad Alhajhusain, Morohonfolu E. Akinnusi, Ranime G. Saliba, Susan V. Lynch, Jeanine P. Wiener-Kronish,